Insider · CIK 0001786720
Serge Saxonov
ceoofficerdirector
Files at TXG (10x Genomics, Inc.). First filing Nov 25, 2024, latest Sep 24, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $2.5M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TXG: 10x Genomics, Inc.
TXGOct 9, 2026 · close 80.65
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | 10x Genomics, Inc. | $2.0M 25,000 shares | -2% | +612% from low0% from high | |
| 51Moderate | 10x Genomics, Inc. | $129k 9,348 shares | -1% | +100% from low-39% from high | |
| 49Moderate | 10x Genomics, Inc. | $78k 9,343 shares | -1% | +20% from low-64% from high | |
| 7Weak | 10x Genomics, Inc. | $84k 7,942 shares | -1% | 0% from low-54% from high | |
| 40Moderate | 10x Genomics, Inc. | $56k 5,092 shares | -1% | +4% from low-52% from high | |
| 42Moderate | 10x Genomics, Inc. | $92k 6,693 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,000 | $78.23 | $78k | 1,074,249 | 18 d ago |
| Sep 22, 2026 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -2,000 | $79.62 | $159k | 1,072,249 | 18 d ago |
| Sep 22, 2026 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -9,300 | $80.90 | $752k | 1,062,949 | 18 d ago |
| Sep 22, 2026 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -9,900 | $81.83 | $810k | 1,053,049 | 18 d ago |
| Sep 22, 2026 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -2,800 | $82.37 | $231k | 1,050,249 | 18 d ago |
| Sep 1, 2026 | TXG 10x Genomics, Inc. | GGift Class A Common Stock | -100 | $0.00 | $0 | 1,075,249 | 39 d ago |
| Sep 12, 2025 | TXG 10x Genomics, Inc. | GGift Class A Common Stock | -900 | $0.00 | $0 | 1,034,817 | Sep 16, 2025 |
| Aug 22, 2025 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -9,348 | $13.79 | $129k | 945,892 | Aug 26, 2025 |
| Jun 9, 2025 | TXG 10x Genomics, Inc. | GGift Class A Common Stock | -1,000 | $0.00 | $0 | 955,240 | Jun 11, 2025 |
| May 29, 2025 | TXG 10x Genomics, Inc. | GGift Class A Common Stock | -3,000 | $0.00 | $0 | 1,080,625 | Jun 2, 2025 |
| May 22, 2025 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -9,343 | $8.30 | $78k | 1,083,625 | May 27, 2025 |
| Mar 17, 2025 | TXG 10x Genomics, Inc. | AGrant or award Class A Common Stock | +171,428 | $0.00 | $0 | 1,092,968 | Mar 19, 2025 |
| Feb 28, 2025 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -7,942 | $10.63 | $84k | 871,540 | Mar 4, 2025 |
| Mar 4, 2025 | TXG 10x Genomics, Inc. | MOption exercise Class A Common Stock10b5-1 | +50,000 | $1.20 | $60k | 921,540 | Mar 4, 2025 |
| Mar 4, 2025 | TXG 10x Genomics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 17,463 | Mar 4, 2025 |
| Feb 24, 2025 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -5,092 | $11.07 | $56k | 879,482 | Feb 26, 2025 |
| Dec 23, 2024 | TXG 10x Genomics, Inc. | MOption exercise Class A Common Stock | +12,000 | $1.20 | $14k | 884,574 | Dec 23, 2024 |
| Dec 23, 2024 | TXG 10x Genomics, Inc. | MOption exercise Stock Option (right to buy)derivative | -12,000 | $0.00 | $0 | 67,463 | Dec 23, 2024 |
| Nov 21, 2024 | TXG 10x Genomics, Inc. | GGift Class A Common Stock | -1,850 | $0.00 | $0 | 879,267 | Nov 25, 2024 |
| Nov 22, 2024 | TXG 10x Genomics, Inc. | SOpen-market sale Class A Common Stock | -6,693 | $13.69 | $92k | 872,574 | Nov 25, 2024 |
| Nov 14, 2024 | TXG 10x Genomics, Inc. | GGift Class A Common Stock | -1,350 | $0.00 | $0 | 881,117 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.